INFOGENE Revenue and Competitors
Estimated Revenue & Valuation
- INFOGENE's estimated annual revenue is currently $37.2M per year.
- INFOGENE's estimated revenue per employee is $159,500
Employee Data
- INFOGENE has 233 Employees.
- INFOGENE grew their employee count by 8% last year.
INFOGENE's People
Name | Title | Email/Phone |
---|
INFOGENE Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.3M | 37 | -16% | N/A | N/A |
#2 | $24.1M | 151 | 94% | N/A | N/A |
#3 | $3.8M | 33 | -21% | N/A | N/A |
#4 | $8.1M | 62 | 5% | N/A | N/A |
#5 | $11.9M | 82 | 37% | N/A | N/A |
#6 | $5.3M | 46 | 5% | N/A | N/A |
#7 | $12.2M | 84 | -12% | N/A | N/A |
#8 | $8M | 61 | 7% | N/A | N/A |
#9 | $8M | 61 | 17% | N/A | N/A |
#10 | $13.5M | 93 | 12% | N/A | N/A |
What Is INFOGENE?
INFOGENE est une ESN spécialisée dans 3 domaines principaux (en AMOA et MOE) : DIGITAL: Notre savoir faire : Conseil, architecture logiciel, conception, développement, maintenance, évolutions de vos portails, vos applications intranet, vos sites marchands. Maîtrise technique de PHP, .NET, J2EE, associée à de fortes compétences métier. BI : Notre savoir-faire : Schéma directeur, conception, développement, maintenance de vos solutions décisionnelles Maîtrise technologique sur SAP BI4, BI Microsoft , SAS BI, SAS BI I INGENIERIE : - Scientifique en R&D (pharma, cosmétique, agroalimentaire, chimie) - Progiciel pharma : ELN, LIMS, CDMS, CTMS, Pharmacovigilance, CRM pharma, transparence, EFPIA - Audit, choix de logiciel, Change Management, Reengineering de process, support applicatif - Infrastructure
keywords:N/AN/A
Total Funding
233
Number of Employees
$37.2M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $30.1M | 274 | 10% | N/A |
#2 | $115M | 418 | 7% | N/A |
#3 | $124M | 684 | 4% | N/A |
#4 | $418.2M | 2060 | 1% | N/A |
#5 | $465.9M | 2295 | N/A | N/A |